Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090179551> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W3090179551 endingPage "221" @default.
- W3090179551 startingPage "212" @default.
- W3090179551 abstract "Background: Leukemia is a severe type of blood cancer that involves an abnormal proliferation of blood-forming cells. Its conventional treatment faces many challenges, including resistance, lack of specificity and high unwanted toxicity of drugs. Nano drug delivery systems help in overcoming these challenges by delivering the drug to the target site actively or passively. Solid lipid nanoparticles are gaining popularity because they reduce unwanted toxicity, are biocompatible, increase bioavailability and are versatile in terms of incorporated agents (hydrophilic as well as lipophilic drugs, genes, enzymes, etc.). Purpose: The aim of this review is to discuss recent advancements in anti-leukemic therapy utilizing solid lipid nanoparticles (SLNs) as successful carriers in enhancing the efficiency of the treatment and bioavailability of the incorporated drug along with overcoming multidrug resistance. Methods: This review represents the existing literature on the applications of SLNs in anti-leukemic therapy. A qualitative literature review has been performed for this purpose. We performed keyword research in popular databases such as Google Scholar, Wiley, Elsevier, Scopus, Google patent and PubMed. Only articles published in English and from reputed journals from specific fields were considered. Benchmark studies having major importance from 2000 to 2020 were selected to follow the progress in the field across the globe. Results: This article improves the understanding of the role of SLNs in the treatment of leukemia. Traditional anti-leukemic therapy involves many challenges, including resistance, lack of specificity and high unwanted toxicity of drugs. SLNs are emerging as a better alternative to conventional delivery systems as they can reduce unwanted toxicity, are biocompatible, and can provide active as well as passive molecular targeting. Conclusion: SLNs provide several advantages in drug delivery for leukemia, including enhancement of efficiency and bioavailability and reduction of toxicity by virtue of their small size, lipid core, non-dependency on organic solvents and versatility in terms of incorporated drugs." @default.
- W3090179551 created "2020-10-08" @default.
- W3090179551 creator A5019365815 @default.
- W3090179551 creator A5019641584 @default.
- W3090179551 creator A5056335829 @default.
- W3090179551 creator A5082597842 @default.
- W3090179551 date "2021-04-19" @default.
- W3090179551 modified "2023-10-16" @default.
- W3090179551 title "Expanding Opportunities in Treatment of Leukemia by Solid Lipid Nanoparticles" @default.
- W3090179551 doi "https://doi.org/10.2174/1570180817999201001155508" @default.
- W3090179551 hasPublicationYear "2021" @default.
- W3090179551 type Work @default.
- W3090179551 sameAs 3090179551 @default.
- W3090179551 citedByCount "1" @default.
- W3090179551 countsByYear W30901795512023 @default.
- W3090179551 crossrefType "journal-article" @default.
- W3090179551 hasAuthorship W3090179551A5019365815 @default.
- W3090179551 hasAuthorship W3090179551A5019641584 @default.
- W3090179551 hasAuthorship W3090179551A5056335829 @default.
- W3090179551 hasAuthorship W3090179551A5082597842 @default.
- W3090179551 hasConcept C114851261 @default.
- W3090179551 hasConcept C126322002 @default.
- W3090179551 hasConcept C171250308 @default.
- W3090179551 hasConcept C185592680 @default.
- W3090179551 hasConcept C192562407 @default.
- W3090179551 hasConcept C199529486 @default.
- W3090179551 hasConcept C2778461978 @default.
- W3090179551 hasConcept C2779820397 @default.
- W3090179551 hasConcept C2780035454 @default.
- W3090179551 hasConcept C71924100 @default.
- W3090179551 hasConcept C86803240 @default.
- W3090179551 hasConcept C89423630 @default.
- W3090179551 hasConcept C98274493 @default.
- W3090179551 hasConceptScore W3090179551C114851261 @default.
- W3090179551 hasConceptScore W3090179551C126322002 @default.
- W3090179551 hasConceptScore W3090179551C171250308 @default.
- W3090179551 hasConceptScore W3090179551C185592680 @default.
- W3090179551 hasConceptScore W3090179551C192562407 @default.
- W3090179551 hasConceptScore W3090179551C199529486 @default.
- W3090179551 hasConceptScore W3090179551C2778461978 @default.
- W3090179551 hasConceptScore W3090179551C2779820397 @default.
- W3090179551 hasConceptScore W3090179551C2780035454 @default.
- W3090179551 hasConceptScore W3090179551C71924100 @default.
- W3090179551 hasConceptScore W3090179551C86803240 @default.
- W3090179551 hasConceptScore W3090179551C89423630 @default.
- W3090179551 hasConceptScore W3090179551C98274493 @default.
- W3090179551 hasIssue "3" @default.
- W3090179551 hasLocation W30901795511 @default.
- W3090179551 hasOpenAccess W3090179551 @default.
- W3090179551 hasPrimaryLocation W30901795511 @default.
- W3090179551 hasRelatedWork W1964896591 @default.
- W3090179551 hasRelatedWork W2121883940 @default.
- W3090179551 hasRelatedWork W2316862923 @default.
- W3090179551 hasRelatedWork W2354043164 @default.
- W3090179551 hasRelatedWork W2564673429 @default.
- W3090179551 hasRelatedWork W2896399282 @default.
- W3090179551 hasRelatedWork W3004607361 @default.
- W3090179551 hasRelatedWork W4376154853 @default.
- W3090179551 hasRelatedWork W2168441468 @default.
- W3090179551 hasRelatedWork W2491030969 @default.
- W3090179551 hasVolume "18" @default.
- W3090179551 isParatext "false" @default.
- W3090179551 isRetracted "false" @default.
- W3090179551 magId "3090179551" @default.
- W3090179551 workType "article" @default.